BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/14/2019 9:34:50 AM | Browse: 1291 | Download: 1894
 |
Received |
|
2019-03-12 06:35 |
|
Peer-Review Started |
|
2019-03-13 02:54 |
|
To Make the First Decision |
|
2019-03-27 05:41 |
|
Return for Revision |
|
2019-03-27 08:12 |
|
Revised |
|
2019-04-02 15:42 |
|
Second Decision |
|
2019-04-19 07:31 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-04-20 01:47 |
|
Articles in Press |
|
2019-04-20 01:47 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-06-13 08:28 |
|
Publish the Manuscript Online |
|
2019-06-14 09:34 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Giovanni Bruno, Piera Zaccari, Giulia Rocco, Giulia Scalese, Cristina Panetta, Barbara Porowska, Stefano Pontone and Carola Severi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Stefano Pontone, MD, PhD, Research Assistant Professor, Department of Surgical Sciences, Sapienza University of Rome, V.le Regina Elena 324, Rome 00161, Italy. stefano.pontone@uniroma1.it |
| Key Words |
Proton pump inhibitors; Hypochloridria; Gut microbiota; Dysbiosis; Gastrointestinal tract; Cancer; Helicobacter pylori; Gastrointestinal infections |
| Core Tip |
The gut microbiota plays a fundamental role in the maintenance of human health. However, several drugs, including proton pump inhibitors, can cause dysbiosis, which in turn is responsible for different extra-intestinal and intestinal diseases. An up-to-date review of the literature was conducted to identify changes in gut microbiota composition related to chronic proton pump inhibitor therapy and to highlight the possible pathogenic involvement of dysbiosis in gastrointestinal disorders. |
| Publish Date |
2019-06-14 09:34 |
| Citation |
Bruno G, Zaccari P, Rocco G, Scalese G, Panetta C, Porowska B, Pontone S, Severi C. Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified. World J Gastroenterol 2019; 25(22): 2706-2719 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i22/2706.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i22.2706 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
